Godrej Agrovet reported mixed financial results for the first quarter of FY27, with consolidated net profit declining 14% year-on-year to ₹128.3 crore compared to ₹149 crore in the corresponding quarter last year. According to latest reports, the profit decline came despite revenue from operations growing 9.2% to ₹2,855.2 crore from ₹2,614.3 crore a year earlier, indicating steady business growth. The company's EBITDA fell 10.9% to ₹240.1 crore from ₹269.6 crore in the previous year, while EBITDA margin contracted to 8.41% from 10.32% year-on-year, showing continued pressure on operational efficiency.
The company faced significant margin compression during the quarter, with EBITDA margin declining 181 basis points to 8.41% from 10.32% a year earlier. As reported by Moneycontrol, this margin contraction indicates that costs increased faster than revenue during the quarter, highlighting the challenge in converting revenue growth into higher profitability. The weaker operating margins weighed on earnings at the bottom line despite the company's ability to generate higher sales compared with the previous year, with PBT declining 10% to ₹181.13 crore from ₹200.49 crore in Q1 FY26.
Godrej Agrovet operates across multiple segments including animal feed, crop protection, oil palm, dairy and poultry, with performance influenced by factors such as commodity prices, input costs, demand trends and market conditions. According to Moneycontrol, the quarterly performance reflects the challenges faced by the company in optimizing operations across these diverse business verticals. The company's subsidiary Godrej Foods adopted the new tax regime during the period, while the company increased its stake in Creamline Dairy Products to 99.78% and its holding in Astec LifeSciences to 67.03%.
Godrej Agrovet made significant infrastructure investments during the quarter, inaugurating India's first Integrated Oil Palm Complex in Telangana with an investment of ₹300 crore on July 20, 2026. This expansion represents the company's aggressive scaling in the oil palm segment. Additionally, credit rating agency ICRA reaffirmed the company's AA/A1+ ratings for its bank facilities and commercial papers on July 28, 2026, indicating strong financial health despite near-term bottomline pressures. The company's long-term structure remains solid, anchored by market leadership in animal nutrition and the aggressive oil palm scaling initiative.
Godrej Agrovet shares ended 0.69% higher at ₹567 in the previous trading session, as reported by Moneycontrol. However, the stock has declined more than 33% from its 52-week high of ₹849.60 and is currently trading 11.9% above its 52-week low of ₹506.70. The mixed quarterly performance, with strong top-line growth offset by margin compression, may have contributed to the stock's underperformance in the longer term. The conflicting signals point to range-bound market action with no strong directional bias, as the strong revenue push provides support while the profit decline might cap significant upward momentum until EBITDA margins display sequential recovery.
